Clinical trial
Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes
NCT00194896 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes
- Lead sponsor
- University of Washington
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2000
- Completion date
- December 31, 2008
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus